Related Experiment Videos
Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal
M Djebaili1, S W Hoffman, D G Stein
1Brain Research Laboratory, Department of Emergency Medicine, 1648 Pierce Drive, Cell Biology Building, Room 261, Emory University, Atlanta, GA 30322, USA.
Neuroscience
|December 31, 2003
Summary
Progesterone and allopregnanolone show similar neuroprotective effects after traumatic brain injury. Allopregnanolone is more potent than progesterone in facilitating central nervous system repair and improving cognitive function.
Area of Science:
- Neuroscience
- Neuropharmacology
- Traumatic Brain Injury Research
Background:
- Traumatic brain injury (TBI) can lead to significant neuronal damage and cognitive deficits.
- Progesterone and its metabolite allopregnanolone have demonstrated neuroprotective properties in various models of central nervous system (CNS) injury.
- Understanding the comparative efficacy of progesterone and allopregnanolone in TBI recovery is crucial for developing targeted therapies.
Purpose of the Study:
- To compare the neuroprotective effects of different doses of allopregnanolone with progesterone following controlled cortical impact (CCI) in adult rats.
- To evaluate the impact of these treatments on apoptosis, lesion size, neuronal loss, and cognitive function post-TBI.
- To determine the relative potency of allopregnanolone compared to progesterone in promoting CNS repair after TBI.
Main Methods:
- Adult rats underwent CCI to the pre-frontal cortex.
- Animals received injections of allopregnanolone (4, 8, or 16 mg/kg), progesterone (16 mg/kg), or vehicle at 1 hour, 6 hours, and daily for 5 days post-injury.
- Assessed caspase-3 activity, DNA fragmentation, necrotic cavity size, cell loss in the thalamus, learning and memory performance, and body weight gain.
Main Results:
- Both progesterone and allopregnanolone treatments reduced caspase-3 activity and DNA fragmentation, indicating decreased apoptosis.
- Allopregnanolone (8 or 16 mg/kg) and progesterone treatments resulted in less cell loss in the thalamus and improved learning and memory compared to vehicle-treated rats.
- While necrotic cavity size was similar across groups, allopregnanolone demonstrated a dose-dependent enhancement of neuroprotection and functional recovery.
Conclusions:
- Progesterone and allopregnanolone exhibit comparable neuroprotective effects in a rat model of TBI.
- Allopregnanolone appears to be a more potent therapeutic agent than progesterone for facilitating CNS repair and mitigating cognitive impairments after TBI.
- These findings suggest that allopregnanolone holds significant promise as a treatment for traumatic brain injury.